A board-certified rheumatologist with more than 20 years of experience, she specializes in systemic lupus erythematosus (SLE), lupus nephritis, autoimmune disease, immunology, and internal medicine. Her clinical and research work focuses heavily on the treatment and long-term management of complex lupus cases, including inflammation-related kidney complications and biologic therapy approaches. She also has more than 5 years of expert witness experience involving consultations and depositions in rheumatology-related matters.

Within academic medicine, she serves as Professor of Clinical Medicine in a university division of rheumatology and directs several major lupus-focused clinical and research programs. Her responsibilities include overseeing lupus patient care, supervising rheumatology clinical trials, and leading observational and epidemiologic studies involving autoimmune disease outcomes and lupus nephritis. She has participated in numerous NIH- and CDC-funded projects involving lupus therapeutics, biomarkers, renal outcomes, racial and socioeconomic disparities, and clinical trial design for autoimmune diseases.

Beyond her clinical and research leadership, she has extensive experience teaching rheumatology, lupus nephritis, and autoimmune disease management to medical students, residents, fellows, and practicing physicians. Her educational work includes development of virtual simulation tools, mobile learning applications, and clinical reasoning curricula focused on lupus diagnosis and treatment. She has authored numerous peer-reviewed publications, review articles, and textbook chapters addressing systemic lupus erythematosus, lupus nephritis, biologic therapies, epidemiology, and rheumatology treatment strategies, and she has served in leadership and peer-review roles with the American College of Rheumatology and other lupus research organizations.